Kilitch Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE729D01010
  • NSEID: KILITCH
  • BSEID: 524500
INR
190.00
-0.32 (-0.17%)
BSENSE

Aug 05, 10:50 AM

BSE+NSE Vol: 6.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
34.96
16.08
16.08
15.58
15.58
15.49
Share Warrants & Outstandings
Total Reserve
244.34
185.89
159.85
130.66
120.65
111.28
Shareholder's Funds
279.65
202.33
176.29
151.60
139.09
127.13
Minority Interest
-2.79
-1.87
-0.62
-1.02
1.21
2.35
Long-Term Borrowings
58.60
27.77
0.00
0.00
0.00
0.00
Secured Loans
58.60
27.77
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-4.58
-2.88
-2.56
-1.98
-1.51
-1.28
Other Long Term Liabilities
0
0
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.68
0.25
0.17
0.07
0.28
0.38
Total Non-Current Liabilities
54.70
25.14
-2.39
-1.91
-1.24
-0.90
Current Liabilities
Trade Payables
79.65
54.16
25.59
40.87
42.87
53.65
Other Current Liabilities
9.62
7.01
5.59
4.29
4.97
4.03
Short Term Borrowings
30.11
21.65
31.65
22.19
20.43
14.80
Short Term Provisions
2.22
1.48
1.39
1.52
1.01
0.83
Total Current Liabilities
121.60
84.31
64.22
68.87
69.28
73.32
Total Liabilities
453.17
309.90
237.50
217.54
208.34
201.90
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
123.80
117.93
112.39
111.28
108.05
71.01
Less: Accumulated Depreciation
57.14
53.52
50.41
47.06
43.51
41.05
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
66.65
64.41
61.98
64.22
64.54
29.96
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
140.02
47.29
5.96
3.62
3.16
65.48
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
22.88
22.84
22.83
22.66
23.93
23.88
Long Term Loans & Advances
1.41
1.42
0.72
0.62
0.46
0.44
Other Non Current Assets
0.00
0.02
0.01
0.02
2.14
1.76
Total Non-Current Assets
230.97
135.99
91.51
91.14
94.23
121.53
Current Assets Loans & Advances
Current Investments
51.96
49.52
49.43
39.20
47.23
36.40
Inventories
11.52
15.31
3.99
2.04
5.00
3.59
Sundry Debtors
120.18
84.74
63.22
54.29
41.41
22.92
Cash and Bank
16.78
9.85
19.64
19.98
10.06
12.50
Other Current Assets
0.81
6.53
1.82
0.57
0.39
0.08
Short Term Loans and Advances
20.95
7.97
7.89
10.33
10.00
4.87
Total Current Assets
222.20
173.92
145.99
126.40
114.10
80.36
Net Current Assets (Including Current Investments)
100.60
89.61
81.78
57.53
44.83
7.05
Total Current Assets Excluding Current Investments
170.23
124.40
96.56
87.21
66.87
43.96
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
453.17
309.90
237.50
217.54
208.34
201.90
Contingent Liabilities
0.76
0.76
1.06
0.76
0.76
0.76
Total Debt
88.71
49.42
31.65
0.00
0.00
0.00
Book Value per share (adjusted)
0
61.5602170583601
107.274969173859
92.0674064940403
87.35051768344
80.2947566202807
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 79.50% vs 56.15% in Mar 2025

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 85.01% vs 64.42% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 0.18% vs 0.04% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 27.76% vs 19.13% in Mar 2025

Compare Balance Sheet Results of Kilitch Drugs
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
34.96
0
34.96
0.00%
Share Warrants & Outstandings
Total Reserve
244.34
0
244.34
0.00%
Shareholder's Funds
279.65
0
279.65
0.00%
Minority Interest
-2.79
0
-2.79
0.00%
Long-Term Borrowings
58.60
0
58.60
0.00%
Secured Loans
58.60
0
58.60
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-4.58
0
-4.58
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.68
0
0.68
0.00%
Total Non-Current Liabilities
54.70
0
54.70
0.00%
Current Liabilities
Trade Payables
79.65
0
79.65
0.00%
Other Current Liabilities
9.62
0
9.62
0.00%
Short Term Borrowings
30.11
0
30.11
0.00%
Short Term Provisions
2.22
0
2.22
0.00%
Total Current Liabilities
121.60
0
121.60
0.00%
Total Liabilities
453.17
0
453.17
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
123.80
0
123.80
0.00%
Less: Accumulated Depreciation
57.14
0
57.14
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
66.65
0
66.65
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
140.02
0
140.02
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
22.88
0
22.88
0.00%
Long Term Loans & Advances
1.41
0
1.41
0.00%
Other Non Current Assets
0.00
0
0.00
0.00%
Total Non-Current Assets
230.97
0
230.97
0.00%
Current Assets Loans & Advances
Current Investments
51.96
0
51.96
0.00%
Inventories
11.52
0
11.52
0.00%
Sundry Debtors
120.18
0
120.18
0.00%
Cash and Bank
16.78
0
16.78
0.00%
Other Current Assets
0.81
0
0.81
0.00%
Short Term Loans and Advances
20.95
0
20.95
0.00%
Total Current Assets
222.20
0
222.20
0.00%
Net Current Assets (Including Current Investments)
100.60
0
100.60
0.00%
Total Current Assets Excluding Current Investments
170.23
0
170.23
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
453.17
0
453.17
0.00%
Contingent Liabilities
0.76
0
0.76
0.00%
Total Debt
88.71
0
88.71
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 88.71 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 79.50% vs 56.15% in Mar 2025

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 206.67 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 85.01% vs 64.42% in Mar 2025

Annual - Investments
Investments 22.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 0.18% vs 0.04% in Mar 2025

Annual - Current Assets
Current Assets 222.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.76% vs 19.13% in Mar 2025